bioRxiv · 10.1101/2021.06.09.447533
Discovering fragment length signatures of circulating tumor DNA using Non-negative Matrix Factorization
Abstract
Sequencing of cell-free DNA (cfDNA) is currently being used to detect cancer by searching both for mutational and non-mutational alterations. Recent work has shown that the length distribution of cfDNA fragments from a cancer patient can inform tumor load and type. Here, we propose non-negative matrix factorization (NMF) of fragment length distributions as a novel method to study fragment lengths in cfDNA samples. Using shallow whole-genome sequencing (sWGS) of cfDNA from a cohort of patients with metastatic castration-resistant prostate cancer (mCRPC), we demonstrate how NMF accurately infers the true tumor fragment length distribution as an NMF component - and that the sample weights of this component correlate with ctDNA levels (r=0.75). We further demonstrate how using several NMF components enables accurate cancer detection on data from various early stage cancers (AUC=0.96). Finally, we show that NMF, when applied across genomic regions, can be used to discover fragment length signatures associated with open chromatin.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Renaud, G., Noergaard, M., Lindberg, J., Groenberg, H., De Laere, B., Jensen, J. B., Borre, M., Andersen, C. L., Soerensen, K. D., Maretty, L., Besenbacher, S.. 2021-06-10. Discovering fragment length signatures of circulating tumor DNA using Non-negative Matrix Factorization. https://doi.org/10.1101/2021.06.09.447533
Cite the original work for its findings. Save a collection to share your selection of sources.